Global Immunotherapy Drugs Market Research Report 2024

Report ID: 1915135 | Published Date: Jan 2025 | No. of Page: 88 | Base Year: 2024 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Immunotherapy Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Monoclonal Antibodies
        1.2.3 Adult Vaccines
        1.2.4 Checkpoint Inhibitors
        1.2.5 Interferons Alpha & Beta
        1.2.6 Interleukins
        1.2.7 Others
    1.3 Market by Application
        1.3.1 Global Immunotherapy Drugs Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Cancer
        1.3.3 Autoimmune & Inflammatory Diseases
        1.3.4 Infectious Diseases
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Immunotherapy Drugs Market Perspective (2017-2028)
    2.2 Immunotherapy Drugs Growth Trends by Region
        2.2.1 Immunotherapy Drugs Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Immunotherapy Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Immunotherapy Drugs Forecasted Market Size by Region (2023-2028)
    2.3 Immunotherapy Drugs Market Dynamics
        2.3.1 Immunotherapy Drugs Industry Trends
        2.3.2 Immunotherapy Drugs Market Drivers
        2.3.3 Immunotherapy Drugs Market Challenges
        2.3.4 Immunotherapy Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Immunotherapy Drugs Players by Revenue
        3.1.1 Global Top Immunotherapy Drugs Players by Revenue (2017-2022)
        3.1.2 Global Immunotherapy Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Immunotherapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Immunotherapy Drugs Revenue
    3.4 Global Immunotherapy Drugs Market Concentration Ratio
        3.4.1 Global Immunotherapy Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Immunotherapy Drugs Revenue in 2021
    3.5 Immunotherapy Drugs Key Players Head office and Area Served
    3.6 Key Players Immunotherapy Drugs Product Solution and Service
    3.7 Date of Enter into Immunotherapy Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Immunotherapy Drugs Breakdown Data by Type
    4.1 Global Immunotherapy Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Immunotherapy Drugs Forecasted Market Size by Type (2023-2028)
5 Immunotherapy Drugs Breakdown Data by Application
    5.1 Global Immunotherapy Drugs Historic Market Size by Application (2017-2022)
    5.2 Global Immunotherapy Drugs Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Immunotherapy Drugs Market Size (2017-2028)
    6.2 North America Immunotherapy Drugs Market Size by Country (2017-2022)
    6.3 North America Immunotherapy Drugs Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Immunotherapy Drugs Market Size (2017-2028)
    7.2 Europe Immunotherapy Drugs Market Size by Country (2017-2022)
    7.3 Europe Immunotherapy Drugs Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Immunotherapy Drugs Market Size (2017-2028)
    8.2 Asia-Pacific Immunotherapy Drugs Market Size by Country (2017-2022)
    8.3 Asia-Pacific Immunotherapy Drugs Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Immunotherapy Drugs Market Size (2017-2028)
    9.2 Latin America Immunotherapy Drugs Market Size by Country (2017-2022)
    9.3 Latin America Immunotherapy Drugs Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Immunotherapy Drugs Market Size (2017-2028)
    10.2 Middle East & Africa Immunotherapy Drugs Market Size by Country (2017-2022)
    10.3 Middle East & Africa Immunotherapy Drugs Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Roche
        11.1.1 Roche Company Detail
        11.1.2 Roche Business Overview
        11.1.3 Roche Immunotherapy Drugs Introduction
        11.1.4 Roche Revenue in Immunotherapy Drugs Business (2017-2022)
        11.1.5 Roche Recent Development
    11.2 Merck
        11.2.1 Merck Company Detail
        11.2.2 Merck Business Overview
        11.2.3 Merck Immunotherapy Drugs Introduction
        11.2.4 Merck Revenue in Immunotherapy Drugs Business (2017-2022)
        11.2.5 Merck Recent Development
    11.3 Novartis
        11.3.1 Novartis Company Detail
        11.3.2 Novartis Business Overview
        11.3.3 Novartis Immunotherapy Drugs Introduction
        11.3.4 Novartis Revenue in Immunotherapy Drugs Business (2017-2022)
        11.3.5 Novartis Recent Development
    11.4 Johnson & Johnson
        11.4.1 Johnson & Johnson Company Detail
        11.4.2 Johnson & Johnson Business Overview
        11.4.3 Johnson & Johnson Immunotherapy Drugs Introduction
        11.4.4 Johnson & Johnson Revenue in Immunotherapy Drugs Business (2017-2022)
        11.4.5 Johnson & Johnson Recent Development
    11.5 Glaxosmithkline
        11.5.1 Glaxosmithkline Company Detail
        11.5.2 Glaxosmithkline Business Overview
        11.5.3 Glaxosmithkline Immunotherapy Drugs Introduction
        11.5.4 Glaxosmithkline Revenue in Immunotherapy Drugs Business (2017-2022)
        11.5.5 Glaxosmithkline Recent Development
    11.6 Amgen
        11.6.1 Amgen Company Detail
        11.6.2 Amgen Business Overview
        11.6.3 Amgen Immunotherapy Drugs Introduction
        11.6.4 Amgen Revenue in Immunotherapy Drugs Business (2017-2022)
        11.6.5 Amgen Recent Development
    11.7 Abbvie
        11.7.1 Abbvie Company Detail
        11.7.2 Abbvie Business Overview
        11.7.3 Abbvie Immunotherapy Drugs Introduction
        11.7.4 Abbvie Revenue in Immunotherapy Drugs Business (2017-2022)
        11.7.5 Abbvie Recent Development
    11.8 Astrazeneca
        11.8.1 Astrazeneca Company Detail
        11.8.2 Astrazeneca Business Overview
        11.8.3 Astrazeneca Immunotherapy Drugs Introduction
        11.8.4 Astrazeneca Revenue in Immunotherapy Drugs Business (2017-2022)
        11.8.5 Astrazeneca Recent Development
    11.9 Bristol-Myers Squibb
        11.9.1 Bristol-Myers Squibb Company Detail
        11.9.2 Bristol-Myers Squibb Business Overview
        11.9.3 Bristol-Myers Squibb Immunotherapy Drugs Introduction
        11.9.4 Bristol-Myers Squibb Revenue in Immunotherapy Drugs Business (2017-2022)
        11.9.5 Bristol-Myers Squibb Recent Development
    11.10 ELI Lilly
        11.10.1 ELI Lilly Company Detail
        11.10.2 ELI Lilly Business Overview
        11.10.3 ELI Lilly Immunotherapy Drugs Introduction
        11.10.4 ELI Lilly Revenue in Immunotherapy Drugs Business (2017-2022)
        11.10.5 ELI Lilly Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Immunotherapy Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Monoclonal Antibodies
    Table 3. Key Players of Adult Vaccines
    Table 4. Key Players of Checkpoint Inhibitors
    Table 5. Key Players of Interferons Alpha & Beta
    Table 6. Key Players of Interleukins
    Table 7. Key Players of Others
    Table 8. Global Immunotherapy Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Immunotherapy Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 10. Global Immunotherapy Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 11. Global Immunotherapy Drugs Market Share by Region (2017-2022)
    Table 12. Global Immunotherapy Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 13. Global Immunotherapy Drugs Market Share by Region (2023-2028)
    Table 14. Immunotherapy Drugs Market Trends
    Table 15. Immunotherapy Drugs Market Drivers
    Table 16. Immunotherapy Drugs Market Challenges
    Table 17. Immunotherapy Drugs Market Restraints
    Table 18. Global Immunotherapy Drugs Revenue by Players (2017-2022) & (US$ Million)
    Table 19. Global Immunotherapy Drugs Market Share by Players (2017-2022)
    Table 20. Global Top Immunotherapy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunotherapy Drugs as of 2021)
    Table 21. Ranking of Global Top Immunotherapy Drugs Companies by Revenue (US$ Million) in 2021
    Table 22. Global 5 Largest Players Market Share by Immunotherapy Drugs Revenue (CR5 and HHI) & (2017-2022)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Immunotherapy Drugs Product Solution and Service
    Table 25. Date of Enter into Immunotherapy Drugs Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Immunotherapy Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 28. Global Immunotherapy Drugs Revenue Market Share by Type (2017-2022)
    Table 29. Global Immunotherapy Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 30. Global Immunotherapy Drugs Revenue Market Share by Type (2023-2028)
    Table 31. Global Immunotherapy Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 32. Global Immunotherapy Drugs Revenue Market Share by Application (2017-2022)
    Table 33. Global Immunotherapy Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 34. Global Immunotherapy Drugs Revenue Market Share by Application (2023-2028)
    Table 35. North America Immunotherapy Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Immunotherapy Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Immunotherapy Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Europe Immunotherapy Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Asia-Pacific Immunotherapy Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 40. Asia-Pacific Immunotherapy Drugs Market Size by Region (2023-2028) & (US$ Million)
    Table 41. Latin America Immunotherapy Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Latin America Immunotherapy Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Middle East & Africa Immunotherapy Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Middle East & Africa Immunotherapy Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Roche Company Detail
    Table 46. Roche Business Overview
    Table 47. Roche Immunotherapy Drugs Product
    Table 48. Roche Revenue in Immunotherapy Drugs Business (2017-2022) & (US$ Million)
    Table 49. Roche Recent Development
    Table 50. Merck Company Detail
    Table 51. Merck Business Overview
    Table 52. Merck Immunotherapy Drugs Product
    Table 53. Merck Revenue in Immunotherapy Drugs Business (2017-2022) & (US$ Million)
    Table 54. Merck Recent Development
    Table 55. Novartis Company Detail
    Table 56. Novartis Business Overview
    Table 57. Novartis Immunotherapy Drugs Product
    Table 58. Novartis Revenue in Immunotherapy Drugs Business (2017-2022) & (US$ Million)
    Table 59. Novartis Recent Development
    Table 60. Johnson & Johnson Company Detail
    Table 61. Johnson & Johnson Business Overview
    Table 62. Johnson & Johnson Immunotherapy Drugs Product
    Table 63. Johnson & Johnson Revenue in Immunotherapy Drugs Business (2017-2022) & (US$ Million)
    Table 64. Johnson & Johnson Recent Development
    Table 65. Glaxosmithkline Company Detail
    Table 66. Glaxosmithkline Business Overview
    Table 67. Glaxosmithkline Immunotherapy Drugs Product
    Table 68. Glaxosmithkline Revenue in Immunotherapy Drugs Business (2017-2022) & (US$ Million)
    Table 69. Glaxosmithkline Recent Development
    Table 70. Amgen Company Detail
    Table 71. Amgen Business Overview
    Table 72. Amgen Immunotherapy Drugs Product
    Table 73. Amgen Revenue in Immunotherapy Drugs Business (2017-2022) & (US$ Million)
    Table 74. Amgen Recent Development
    Table 75. Abbvie Company Detail
    Table 76. Abbvie Business Overview
    Table 77. Abbvie Immunotherapy Drugs Product
    Table 78. Abbvie Revenue in Immunotherapy Drugs Business (2017-2022) & (US$ Million)
    Table 79. Abbvie Recent Development
    Table 80. Astrazeneca Company Detail
    Table 81. Astrazeneca Business Overview
    Table 82. Astrazeneca Immunotherapy Drugs Product
    Table 83. Astrazeneca Revenue in Immunotherapy Drugs Business (2017-2022) & (US$ Million)
    Table 84. Astrazeneca Recent Development
    Table 85. Bristol-Myers Squibb Company Detail
    Table 86. Bristol-Myers Squibb Business Overview
    Table 87. Bristol-Myers Squibb Immunotherapy Drugs Product
    Table 88. Bristol-Myers Squibb Revenue in Immunotherapy Drugs Business (2017-2022) & (US$ Million)
    Table 89. Bristol-Myers Squibb Recent Development
    Table 90. ELI Lilly Company Detail
    Table 91. ELI Lilly Business Overview
    Table 92. ELI Lilly Immunotherapy Drugs Product
    Table 93. ELI Lilly Revenue in Immunotherapy Drugs Business (2017-2022) & (US$ Million)
    Table 94. ELI Lilly Recent Development
    Table 95. Research Programs/Design for This Report
    Table 96. Key Data Information from Secondary Sources
    Table 97. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Immunotherapy Drugs Market Share by Type: 2021 VS 2028
    Figure 2. Monoclonal Antibodies Features
    Figure 3. Adult Vaccines Features
    Figure 4. Checkpoint Inhibitors Features
    Figure 5. Interferons Alpha & Beta Features
    Figure 6. Interleukins Features
    Figure 7. Others Features
    Figure 8. Global Immunotherapy Drugs Market Share by Application in 2021 & 2028
    Figure 9. Cancer Case Studies
    Figure 10. Autoimmune & Inflammatory Diseases Case Studies
    Figure 11. Infectious Diseases Case Studies
    Figure 12. Others Case Studies
    Figure 13. Immunotherapy Drugs Report Years Considered
    Figure 14. Global Immunotherapy Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 15. Global Immunotherapy Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Immunotherapy Drugs Market Share by Region: 2021 VS 2028
    Figure 17. Global Immunotherapy Drugs Market Share by Players in 2021
    Figure 18. Global Top Immunotherapy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunotherapy Drugs as of 2021)
    Figure 19. The Top 10 and 5 Players Market Share by Immunotherapy Drugs Revenue in 2021
    Figure 20. North America Immunotherapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. North America Immunotherapy Drugs Market Share by Country (2017-2028)
    Figure 22. United States Immunotherapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Canada Immunotherapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Immunotherapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Europe Immunotherapy Drugs Market Share by Country (2017-2028)
    Figure 26. Germany Immunotherapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France Immunotherapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. Immunotherapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy Immunotherapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia Immunotherapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries Immunotherapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Immunotherapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Immunotherapy Drugs Market Share by Region (2017-2028)
    Figure 34. China Immunotherapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Japan Immunotherapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. South Korea Immunotherapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Southeast Asia Immunotherapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. India Immunotherapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Australia Immunotherapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Latin America Immunotherapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Latin America Immunotherapy Drugs Market Share by Country (2017-2028)
    Figure 42. Mexico Immunotherapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Brazil Immunotherapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Middle East & Africa Immunotherapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Middle East & Africa Immunotherapy Drugs Market Share by Country (2017-2028)
    Figure 46. Turkey Immunotherapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Saudi Arabia Immunotherapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Roche Revenue Growth Rate in Immunotherapy Drugs Business (2017-2022)
    Figure 49. Merck Revenue Growth Rate in Immunotherapy Drugs Business (2017-2022)
    Figure 50. Novartis Revenue Growth Rate in Immunotherapy Drugs Business (2017-2022)
    Figure 51. Johnson & Johnson Revenue Growth Rate in Immunotherapy Drugs Business (2017-2022)
    Figure 52. Glaxosmithkline Revenue Growth Rate in Immunotherapy Drugs Business (2017-2022)
    Figure 53. Amgen Revenue Growth Rate in Immunotherapy Drugs Business (2017-2022)
    Figure 54. Abbvie Revenue Growth Rate in Immunotherapy Drugs Business (2017-2022)
    Figure 55. Astrazeneca Revenue Growth Rate in Immunotherapy Drugs Business (2017-2022)
    Figure 56. Bristol-Myers Squibb Revenue Growth Rate in Immunotherapy Drugs Business (2017-2022)
    Figure 57. ELI Lilly Revenue Growth Rate in Immunotherapy Drugs Business (2017-2022)
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation
    Figure 60. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche
Merck
Novartis
Johnson & Johnson
Glaxosmithkline
Amgen
Abbvie
Astrazeneca
Bristol-Myers Squibb
ELI Lilly
Frequently Asked Questions
Immunotherapy Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Immunotherapy Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Immunotherapy Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports